Search results
Results from the WOW.Com Content Network
Modafinil is also approved for stimulating wakefulness in people with sleep apnea and shift work sleep disorder. [3] It is taken by mouth. [3] [8] Modafinil is not approved by the US Food and Drug Administration (FDA) for use in people under 17 years old. [8] Common side effects of Modafinil include anxiety, insomnia, dizziness, and headache.
Modafinil (brand name Provigil) is a stimulant approved in the US for treatment of shift-work sleep disorder, which shares some characteristics with DSPD. A number of clinicians prescribe it for DSPD patients, as it may improve a sleep-deprived patient's ability to function adequately during socially desirable hours.
A Cephalon-founded study in which patients were administered modafinil, methylphenidate, and a placebo found that modafinil produces "psychoactive and euphoric effects and feelings consistent with [methylphenidate]." [12] Like modafinil, armodafinil is an inhibitor and/or inducer of certain cytochrome P450 enzymes.
Idiopathic hypersomnia (IH) is a neurological disorder which is characterized primarily by excessive sleep and excessive daytime sleepiness (EDS). [1] Idiopathic hypersomnia was first described by Bedrich Roth in 1976, and it can be divided into two forms: polysymptomatic and monosymptomatic.
Provigil was initially approved to treat excessive daytime sleepiness resulting from narcolepsy, and later approved the drug for further label indications. Cephalon allegedly promoted Provigil for a five-year period as a non-stimulant drug for the treatment of sleepiness, tiredness, decreased activity, lack of energy, and fatigue. [16]
The clinic also spent nearly $100,000 during that period on Provigil, a stimulant that is “55 times more expensive than the generic equivalent,” the report said. In 2019, investigators tried ...
It is also approved for weight loss in those that are either obese or overweight with some weight-related illnesses Cymbalta ( duloxetine ) – an antidepressant of the serotonin-norepinephrine reuptake inhibitors class
As of November 2012, medications approved as no-go pills by the U.S. Air Force for aircrew and AFSOC [1] forces include: Temazepam (Restoril), with a 12-hour restriction on subsequent flight operation; Zaleplon (Sonata), with a 4-hour restriction on subsequent flight operation; Zolpidem (Ambien), with a 6-hour restriction on subsequent flight ...